Cilag

ASH18: Argenx pens $1.6B biobucks Janssen pact for blood cancer hopeful cusatuzumab
Fierce Biotech
Mon, 12/3/18 - 09:55 am
Argenx
Cilag
Janssen
cusatuzumab
ASH2018
blood cancers
AstraZeneca conducts fourth sale this week
BioPharma Dive
Fri, 10/7/16 - 10:27 pm
AstraZeneca
JNJ
Cilag
Rhinocort Aqua